Anonymous
Not logged in
Talk
Contributions
Create account
Log in
Search
Editing
Hector Bonilla
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Namespaces
Page
Discussion
More
More
Page actions
Read
Edit
Edit source
History
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
{{NeedsImage}} '''Hector Bonilla''', MD, is an infectious disease doctor and researcher at [[Stanford University]], specializing in HIV/AIDS, [[Hepatitis C|Hepatitis C virus]] (HCV), [[Myalgic encephalomyelitis|ME/CFS]]. He received a 2018 [[Ramsay Award Program|Ramsay Award]] from the [[Solve ME/CFS Initiative]] for a genetics project on ME/CFS and the herpes virus. The research follows on his preliminary findings that [[herpes simplex virus]] (HSV) type 1 infection in the sera of individuals with ME/CFS is related to severity of the disease. == Education and training == Dr. Bonilla earned his medical degree (1983) from the Universidad del Valle School of Medicine in Cali, Colombia, where he later served as chief resident in internal medicine (1988).<ref name="profile">{{Cite web | url = https://profiles.stanford.edu/hector-bonilla | title = Hector Bonilla's Profile | last = | first = | authorlink = | date = | website = profiles.stanford.edu| publisher = Stanford University|language=en|archive-url=|archive-date=|url-status=|access-date=2019-03-29}}</ref> He subsequently conducted a residency at Sinai Hospital of Detroit, earning board certification in internal medicine from the American Board of Internal Medicine in 1994.<ref name="profile" /> He next completed a fellowship in infectious diseases at University of Michigan and earned board certification in infectious diseases from the American Board of Internal Medicine in 1996.<ref name="profile" /> ==Career and appointments== Dr. Bonilla's early career experience focused on treating [[HIV|HIV/AIDS]] and [[Hepatitis C|Hepatitis C Virus]] at a time when both diseases faced stigma and research neglect for effective treatments.<ref name="Stanford">{{Cite web | url = https://stanfordhealthcare.org/doctors/b/hector-bonilla.html | title = Hector Bonilla|website=stanfordhealthcare.org|access-date=2019-03-29}}</ref> He worked at Louisiana State University, then Summa Health System in Akron, Ohio, and he grew increasingly interested in clinical research.<ref name="Stanford" /> Pursuing these subjects, he joined the University Of Pittsburgh Medical Center as Assistant Professor, Clinician, and Medical Educator in the Department of Medicine in the Division of Infectious Diseases, then later ImmunoScience Inc., a biotechnology company in California working to develop a therapeutic HIV vaccine, due to his interest in [[cytokine]]s and [[Immune system|immunological responses]].<ref name="Stanford" /> Dr. Bonilla's interest in [[Inflammation|inflammatory response]] as well as his experience treating HIV and HCV drew him to the subject of ME/CFS.<ref name="Stanford" /> He is currently Clinical Assistant Professor, Medicine - Infectious Diseases, at Stanford University<ref name="profile" /> and a positive care doctor at the Stanford's Infectious Disease Clinic.<ref name="Stanford" /> His biography at Stanford describes: "His ME/CFS patients are his inspiration, and he is committed to continuing research to seek answers to their health challenges."<ref name="Stanford" /> He received a 2018 Ramsay Award from the [[Solve ME/CFS Initiative]] for a "Cross-sectional study to assess the prevalence of [[APOE]] e4 alleles in patients with ME/CFS and the association with herpes virus infection”.<ref name="solvecfs">{{Cite web | url = https://solvecfs.org/hector-bonilla/ | title = Hector Bonilla|website=Solve ME/CFS Initiative|language=en-US|access-date=2019-03-29}}</ref> The project follows on preliminary findings that [[herpes simplex virus]] (HSV) type 1 infection in the sera of individuals with ME/CFS is related to severity of the disease.<ref name="solvecfs" /> ==Interviews and news articles == ==Notable studies and publications == *2021, Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole<ref name="Crosby2021">{{Cite journal | last = Crosby | first = L.D. | authorlink = | last2 = Kalanidhi | first2 = S. | authorlink2 = | last3 = Bonilla | first3 = A. | authorlink3 = | last4 = Subramanian | first4 = A. | authorlink4 = | last5 = Ballon | first5 = J.S. | authorlink5 = | last6 = Bonilla | first6 = H. | authorlink6 = Hector Bonilla | date = 2021-02-03 | title = Off label use of Aripiprazole shows promise as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a retrospective study of 101 patients treated with a low dose of Aripiprazole| url = https://doi.org/10.1186/s12967-021-02721-9|journal=Journal of Translational Medicine|language=en|volume=19|issue=1 | pages = 50|doi=10.1186/s12967-021-02721-9|issn=1479-5876|pmc=PMC7860172|pmid=33536023|access-date=|quote=|via=}}</ref> [https://doi.org/10.1186/s12967-021-02721-9 (Full text)] ::[https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-021-02875-6 correction] *2021, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management. Mayo Clinic Proceedings<ref name="Bateman2021">https://www.mayoclinicproceedings.org/article/S0025-6196(21)00513-9/fulltext</ref> [https://www.mayoclinicproceedings.org/article/S0025-6196(21)00513-9/fulltext (Full text)] *Patients with uncomplicated COVID-19 have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic<ref name="Jacobson2021">https://academic.oup.com/cid/article/73/3/e826/6129932</ref> [https://academic.oup.com/cid/article/73/3/e826/6129932 (Full text)] == Clinic location == 3351 El Camino Real, Suite 225 Atherton, CA 94027 (650) 736-5200 ==Online presence == ==Learn more == ==See also == *[[Aripiprazole]] (Abilify) *[[Solve ME/CFS Initiative]] ==References== {{reflist}} [[Category:Researchers]] [[Category:US researchers]] [[Category:Clinicians]] [[Category:California clinicians]]
Summary:
Please make sure your edits are consistent with
MEpedia's guidelines
.
By saving changes, you agree to the
Terms of use
, and you irrevocably agree to release your contribution under the
CC BY-SA 3.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)
Templates used on this page:
Template:Cite journal
(
edit
)
Template:Cite web
(
edit
)
Template:Main other
(
edit
)
Template:NeedsImage
(
edit
)
Template:Reflist
(
edit
)
Module:Check for unknown parameters
(
edit
)
Module:Citation/CS1
(
edit
)
Module:Citation/CS1/COinS
(
edit
)
Module:Citation/CS1/Configuration
(
edit
)
Module:Citation/CS1/Date validation
(
edit
)
Module:Citation/CS1/Identifiers
(
edit
)
Module:Citation/CS1/Utilities
(
edit
)
Module:Citation/CS1/Whitelist
(
edit
)
Module:No globals
(
edit
)
This page is a member of a hidden category:
Category:Articles that need an image or photo
Navigation
Navigation
Skip to content
Main page
Browse
Become an editor
Random page
Popular pages
Abbreviations
Glossary
About MEpedia
Links for editors
Contents
Guidelines
Recent changes
Pages in need
Search
Help
Wiki tools
Wiki tools
Special pages
Page tools
Page tools
User page tools
More
What links here
Related changes
Page information
Page logs